Baxter
BAX
#2139
Rank
NZ$15.11 B
Marketcap
NZ$29.29
Share price
6.33%
Change (1 day)
-50.87%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

EPS for Baxter (BAX)

EPS in 2025 (TTM): NZ-$3.20

According to Baxter's latest financial reports the company's current EPS (TTM) is NZ-$3.23. a decrease over its 2024 EPS that were of NZ-$2.23.

EPS history for Baxter from 2011 to 2025

Annual EPS

Year EPS Change
2025NZ-$3.2344.53%
2024NZ-$2.23-124.43%
2023NZ$9.13-208.49%
2022NZ-$8.42-288.67%
2021NZ$4.4618.52%
2020NZ$3.77
2018NZ$5.30130.3%
2017NZ$2.30
2015NZ$3.09-61.48%
2014NZ$8.0224.32%
2013NZ$6.45-12.32%
2012NZ$7.367.93%
2011NZ$6.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Medtronic
MDT
NZ$6.26-294.05%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
NZ$30.98-1,060.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.52-395.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$3.42-205.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$14.80-558.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$12.19-477.84%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ-$0.54-83.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$4.55-241.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
NZ-$30.34 840.72%๐Ÿ‡บ๐Ÿ‡ธ USA